QPPV.COM KNOWLEDGE ASSESSMENT

Hydroxyzine: Discovery, Development, Safety and Pharmacovigilance — Professional Knowledge Assessment

Test your understanding of the concepts covered by Hydroxyzine: Discovery, Development, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which finding would most directly support updating a suspected syncope case to include confirmed torsade de pointes?
Question 2 of 10 A patient being treated for pruritus develops a new rash during hydroxyzine therapy. What is the best assessment principle?
Question 3 of 10 A frequency reported in the French ATARAX product information is being considered for a US hydroxyzine tablet case. What is the appropriate use of that information?
Question 4 of 10 A patient taking hydroxyzine becomes drowsy and falls after drinking alcohol. Which assessment is most appropriate?
Question 5 of 10 Which pairing correctly distinguishes pharmacodynamic from pharmacokinetic interaction concerns for hydroxyzine?
Question 6 of 10 What does concentration-dependent inhibition of hERG potassium channels contribute to the assessment of hydroxyzine’s cardiac risk?
Question 7 of 10 Which statement best distinguishes symptomatic relief of pruritus from treatment of the underlying disease?
Question 8 of 10 An apparent increase in hydroxyzine-associated arrhythmia reports is detected. What should be reviewed before interpreting the increase as a signal of changing risk?
Question 9 of 10 A reporter states that a patient “fainted after a tablet,” but no ECG is available. What is the most appropriate case-handling approach?
Question 10 of 10 A patient with renal impairment reports persistent sedation after hydroxyzine. Which interpretation is most defensible?

Select an answer to continue.

QPPV.com